Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Kristian Jackson

  • Home
  • Author: Kristian Jackson

P&G needs to mitigate impact of growing production costs to drive earnings forward despite showing positive net sales growth in Q4 results

‘‘P&G’s fourth quarter results indicate positive net sales growth of 3%. However an increase in costs of 9% in its supply chain has served to reduce net earnings compared with the same period in 2017. The company will need to reduce its supply and manufacturing overheads or consider increasing its prices to mitigate the impact of growing commodity costs experienced across the consumer goods landscape on its bottom line.
Read more

Stagnating Tim Hortons brand remains a challenge for Restaurant Brands International following Q2 results announcement

‘‘While there are positives to take from Restaurant Brands International’s Q2 earning release, they do little to allay the fears of investors who feel the firm is struggling to turn around the stagnating Tim Hortons brand. The company needs to be more innovative and introduce something which can really attract the attention of consumers or resign itself to playing second fiddle to rivals.
Read more

Top 25 Global Technology Companies by Market Cap (Q1 2018)

The performance highlights of the Top 25 publicly traded global technology companies by Market Cap (Mcap) between the last day of Q1 2018 and the last day of Q4 2017 have been analysed in the latest research from GlobalData, a leading data and analytics company. The completed day vs day (31 Mar 2018 vs 31 Dec 2017) analysis reveals a number of interesting insights.
Read more

Humdrum sales increase shows why Sainsbury’s needs ASDA – and the sooner the better

“While Sainsbury’s focuses on getting its pending merger with ASDA past the CMA for the end of 2019, day-to-day retail operations continue – and as the first quarter numbers show, performance is far from impressive. While all key metrics are at least positive, a 0.2% growth in retail like-for-like sales sits far behind the recent results of competitors Tesco (+2.1%) and Morrisons (+3.6%) over a comparable period.
Read more

Takeda chases after its largest deal yet

Takeda’s possible $65B takeover of Shire could be the largest deal value in pharma this year, says GlobalData a leading data and analytics company. This is the Japanese company’s fifth attempt at merging with Shire, clearly highlighting Takeda’s readiness for this move. Notably, this deal is significantly larger than Takeda’s acquisition of Millennium in 2008 (for $8.8B), Nycomed in 2011 (for $13.7B), and Ariad in 2017 (for $5.2B).
Read more
1 2 3 4 5 6 … 13